Michael W. Dunne
- Virology top 1%
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 21
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 13
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 11
-
- Antibiotics Pharmacokinetics and Efficacy 23
-
- Urinary Tract Infections Management 14
- Mycobacterium research and diagnosis 6
- Pneumonia and Respiratory Infections 6
-
- Streptococcal Infections and Treatments 6
- Co-authors
- Sailaja PuttaguntaHelen W. BoucherGeorge H. TalbotAnita DasSik Hung NgJames BaldassarreMark WilcoxMichael T. Zelasky
- Partner nations
- United StatesUnited KingdomNew Zealand
In The Last Decade
Michael W. Dunne
86 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Applied Microbiology and Biotechnology 236
- Virology 518
- Infectious Diseases 1.9k
- Clinical Biochemistry 591
- Molecular Medicine 311
Countries citing papers authored by Michael W. Dunne
This map shows the geographic impact of Michael W. Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Dunne more than expected).
Fields of papers citing papers by Michael W. Dunne
This network shows the impact of papers produced by Michael W. Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Dunne. The network helps show where Michael W. Dunne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael W. Dunne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 26 | |
| 8 | 2015 | 15 | |
| 9 | 2015 | 58 | |
| 10 | 2015 | 33 | |
| 11 | 2013 | 4 | |
| 12 | Maraviroc for Previously Treated Patients with R5 HIV-1 Infectionbreakdown → | 2008 | 570 |
| 13 | 2005 | 57 | |
| 14 | Thomas Aquinas, Approaches to truth : the Aquinas lectures at maynooth, 1996-2001 | 2002 | 4 |
| 15 | Mind, Metaphysics and Value in the Thomistic and Analytical Traditions | 2002 | 7 |
| 16 | 2001 | 107 | |
| 17 | 2000 | 3 | |
| 18 | 1998 | 49 | |
| 19 | 1998 | 9 | |
| 20 | 1998 | 59 |
About Michael W. Dunne
Michael W. Dunne is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 89 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antimicrobial Resistance in Staphylococcus (21 papers), Urinary Tract Infections Management (14 papers), Bacterial Identification and Susceptibility Testing (13 papers), Antibiotic Resistance in Bacteria (11 papers), Mycobacterium research and diagnosis (6 papers), Streptococcal Infections and Treatments (6 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (236 citations), Virology (518 citations) and Infectious Diseases (1.9k citations). Michael W. Dunne has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Sailaja Puttagunta, Helen W. Boucher, George H. Talbot, Anita Das, Sik Hung Ng, James Baldassarre, Mark Wilcox, Michael T. Zelasky, Marc Wilson and Steve Felstead. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.